Zonisamide-induced long-lasting recovery of dopaminergic neurons from MPTP-toxicity
Authors:
- Win Thiri KyawWin Thiri Kyaw
- Masahiro NomotoMNMasahiro Nomoto
- 1 April 2011
- journal article
- Published by Elsevier in Brain Research
- Vol. 1384, 170-178
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Health, Labour and Welfare
This publication has 22 references indexed in Scilit:
- The antiepileptic drug zonisamide inhibits MAO-B and attenuates MPTP toxicity in mice: Clinical relevanceExperimental Neurology, 2010
- Electrophysiological actions of zonisamide on striatal neurons: Selective neuroprotection against complex I mitochondrial dysfunctionExperimental Neurology, 2010
- Neuroprotective effects of zonisamide target astrocyteAnnals of Neurology, 2009
- Time dependent alterations of co-localization of S100β and GFAP in the MPTP-treated miceJournal of Neural Transmission, 2006
- Intracellular and extracellular roles of S100 proteinsMicroscopy Research and Technique, 2003
- S-100β protein is upregulated in astrocytes and motor neurons in the spinal cord of patients with amyotrophic lateral sclerosisNeuroscience Letters, 1999
- Implication of Astroglia in the Blood‐Brain BarrierAnnals of the New York Academy of Sciences, 1991
- The release and uptake of excitatory amino acidsTrends in Pharmacological Sciences, 1990
- Role of glial cells in the regulation of the brain ion microenvironmentProgress in Neurobiology, 1989
- Pilot Study of Zonisamide (1,2‐Benzisoxazole‐3‐methanesulfonamide) in Patients with Refractory Partial SeizuresEpilepsia, 1985